| 51 | Targeted Therapies In Combination With Hormonal Therapy As A First-Line Treatment For HR Positive And HER2 Negative Metastatic Breast Cancer | 2021 |  |
| 52 | Acupuncture For Headache, Refractory Neuralgia, Bell’s Palsy, Post-Stroke, Guillain Barre And Transverse Myelitis | 2021 | |
| 53 | Refurbish Medical Device | 2021 | |
| 54 | Pulsed Electromagnetic Field Therapy- An Update | 2021 | |
| 55 | Using Laser Flourescence To Detect Tooth Decay | 2021 | |
| 56 | Versajet Hydrosurgery System For Wound Debridement | 2021 | |
| 57 | Rezūm Therapy for Management of Benign Prostatic Hyperplasia | 2021 | |
| 58 | Repetitive Transcranial Magnetic Stimulation (rTMS) For Patient With Stroke | 2021 | |
| 59 | Rezūm Therapy for Management of Benign Prostatic Hyperplasia | 2021 | |
| 60 | Hepatitis C Virus Screening And Surveillance Tests For Dialysis Patients | 2021 | |
| 61 | Human Papillomavirus (HPV) Vaccination-An Update | 2021 | |
| 62 | Single Dose Rifampicin (SDR) as a Prophylaxis for Ieprosy Contacts | 2021 | |
| 63 | Prophylactic Anticoagulation In Ambulatory Cancer Patients | 2020 | |
| 64 | Digital Dental Impression | 2020 | |
| 65 | Automatic Guided Vehicles (AGVS) For Transportation Of Food And Materials In Hospitals | 2020 | |
| 66 | Cinacalcet For The Treatment Of Secondary Hyperparathyroidism In End Stage Renal Failure And Economic Evaluation | 2020 | |
| 67 | Needleless Vacutainer System For Blood Collection | 2020 | |
| 68 | Intravenous Iron For Iron Deficiency Anaemia | 2020 | |
| 69 | Biocompatible Peritoneal Dialysis (PD) Solution | 2020 | |
| 70 | Influenza Vaccination For The Elderly And Economic Evaluation | 2020 | |
| 71 | Programmatic Management Of Latent Tuberculosis Infection | 2020 | |
| 72 | Antifibrotic For Treatment Of Idiopathic Pulmonary Fibrosis | 2020 | |
| 73 | SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS VERSUS GLICLAZIDE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS | 2019 | |
| 74 | INTRADERMAL (ID) INJECTION OF RABIES VACCINE: POST-EXPOSURE (PEP) AND PRE-EXPOSURE (PrEP) PROPHYLAXIS & ECONOMIC EVALUATION | 2019 | |
| 75 | Nonavalent HPV Vaccine (GARDASIL 9) | 2019 | |
.png)
